Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnosis and outcomes of cachexia in Asia: Working Consensus Report from the Asian Working Group for Cachexia.
Arai H, Maeda K, Wakabayashi H, Naito T, Konishi M, Assantachai P, Auyeung WT, Chalermsri C, Chen W, Chew J, Chou MY, Hsu CC, Hum A, Hwang IG, Kaido T, Kang L, Kamaruzzaman SB, Kim M, Lee JSW, Lee WJ, Liang CK, Lim WS, Lim JY, Lim YP, Lo RS, Ong T, Pan WH, Peng LN, Pramyothin P, Razalli NH, Saitoh M, Shahar S, Shi HP, Tung HH, Uezono Y, von Haehling S, Won CW, Woo J, Chen LK. Arai H, et al. Among authors: uezono y. J Cachexia Sarcopenia Muscle. 2023 Oct;14(5):1949-1958. doi: 10.1002/jcsm.13323. Epub 2023 Sep 5. J Cachexia Sarcopenia Muscle. 2023. PMID: 37667992 Free PMC article. Review.
A multi-centre, double-blind, randomized, placebo-controlled trial to evaluate the effectiveness and safety of ramelteon for the prevention of postoperative delirium in elderly cancer patients: a study protocol for JORTC-PON2/J-SUPPORT2103/NCCH2103.
Sadahiro R, Hatta K, Yamaguchi T, Masanori E, Matsuda Y, Ogawa A, Iwata Y, Tokoro A, Nakahara R, Hirayama T, Yanai Y, Ogawa Y, Kayano A, Ariyoshi K, Oyamada S, Uchitomi Y, Akechi T, Yamamoto N, Okita N, Yorikane E, Shimada K, Furukawa T, Hashimoto H, Maeda M, Sato T, Sekimoto A, Sasaki C, Saito E, Uezono Y, Matsuoka H. Sadahiro R, et al. Among authors: uezono y. Jpn J Clin Oncol. 2023 Aug 30;53(9):851-857. doi: 10.1093/jjco/hyad061. Jpn J Clin Oncol. 2023. PMID: 37340766 Free PMC article.
Therapeutic Potential of Orally Administered Rubiscolin-6.
Karasawa Y, Miyano K, Yamaguchi M, Nonaka M, Yamaguchi K, Iseki M, Kawagoe I, Uezono Y. Karasawa Y, et al. Among authors: uezono y. Int J Mol Sci. 2023 Jun 9;24(12):9959. doi: 10.3390/ijms24129959. Int J Mol Sci. 2023. PMID: 37373107 Free PMC article. Review.
Distinct Profiles of Desensitization of µ-Opioid Receptors Caused by Remifentanil or Fentanyl: In Vitro Assay with Cells and Three-Dimensional Structural Analyses.
Uezono E, Mizobuchi Y, Miyano K, Ohbuchi K, Murata H, Komatsu A, Manabe S, Nonaka M, Hirokawa T, Yamaguchi K, Iseki M, Uezono Y, Hayashida M, Kawagoe I. Uezono E, et al. Among authors: uezono y. Int J Mol Sci. 2023 May 6;24(9):8369. doi: 10.3390/ijms24098369. Int J Mol Sci. 2023. PMID: 37176075 Free PMC article.
Evaluation of the Intracellular Signaling Activities of κ-Opioid Receptor Agonists, Nalfurafine Analogs; Focusing on the Selectivity of G-Protein- and β-Arrestin-Mediated Pathways.
Yamaguchi M, Miyano K, Hirayama S, Karasawa Y, Ohshima K, Uezono E, Komatsu A, Nonaka M, Fujii H, Yamaguchi K, Iseki M, Hayashida M, Uezono Y. Yamaguchi M, et al. Among authors: uezono y, uezono e. Molecules. 2022 Oct 19;27(20):7065. doi: 10.3390/molecules27207065. Molecules. 2022. PMID: 36296658 Free PMC article.
Discovery of 7-Azanorbornane-Based Dual Agonists for the Delta and Kappa Opioid Receptors through an In Situ Screening Protocol.
Karaki F, Takamori T, Kawakami K, Sakurai S, Hidaka K, Ishii K, Oki T, Sato N, Atsumi N, Ashizawa K, Taguchi A, Ura A, Naruse T, Hirayama S, Nonaka M, Miyano K, Uezono Y, Fujii H. Karaki F, et al. Among authors: uezono y. Molecules. 2023 Oct 3;28(19):6925. doi: 10.3390/molecules28196925. Molecules. 2023. PMID: 37836768 Free PMC article.
G protein-biased LPAR1 agonism of prototypic antidepressants: Implication in the identification of novel therapeutic target for depression.
Kajitani N, Okada-Tsuchioka M, Inoue A, Miyano K, Masuda T, Boku S, Iwamoto K, Ohtsuki S, Uezono Y, Aoki J, Takebayashi M. Kajitani N, et al. Among authors: uezono y. Neuropsychopharmacology. 2024 Feb;49(3):561-572. doi: 10.1038/s41386-023-01727-9. Epub 2023 Sep 6. Neuropsychopharmacology. 2024. PMID: 37673966 Free PMC article.
244 results